National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 48682-48683 [2022-17142]
Download as PDF
<![CDATA[
48682
Federal Register / Vol. 87, No. 153 / Wednesday, August 10, 2022 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting
website https://videocast.nih.gov/
watch=45856.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Nursing Research.
Date: September 13, 2022.
Open: 11:00 a.m. to 3:30 p.m.
Agenda: Discussion of Program Policies
and Issues.
Place: National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Boulevard, One Democracy Plaza,
Bethesda, MD 20892, https://
videocast.nih.gov/watch=45856 (Virtual
Meeting).
Closed: 3:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate review of
Applications.
Place: National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Boulevard, One Democracy Plaza,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dr. Elizabeth Tarlov,
Ph.D., RN, Director, Division of Extramural
Science Programs (DESP), National Institute
of Nursing Research, 31 Center Drive,
Bethesda, MD 20892, (301) 594–1580,
elizabeth.tarlov@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninr.nih.gov/aboutninr/nacnr, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: August 4, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–17143 Filed 8–9–22; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:26 Aug 09, 2022
Jkt 256001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Resource
Development Network for Longitudinal
behavioral and social studies.
Date: September 6, 2022.
Time: 11:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Rajasri Roy, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, Gateway Building
2W200, 7201 Wisconsin Avenue, Bethesda,
MD 20892, (301) 496–6477, rajasri.roy@
nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.nia.nih.gov/, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 4, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–17083 Filed 8–9–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of Centers of Biomedical
Research Excellence (COBRE) Phase III (P30)
Applications.
Date: November 10, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medicine
Science, Natcher Bldg 45, 45 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Manas Chattopadhyay,
Ph.D., National Institutes of Health, 45 Center
Dr, Bethesda, MD 20872, manasc@
mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.nigms.nih.gov/, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: August 4, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–17084 Filed 8–9–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting of the National
Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
E:\FR\FM\10AUN1.SGM
10AUN1
Federal Register / Vol. 87, No. 153 / Wednesday, August 10, 2022 / Notices
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
Subpart
M—Medical Review Officer (MRO),
Section 13.2 of the Mandatory
Guidelines, ‘‘How are nationally
recognized entities or subspecialty
boards that certify MROs approved?’’
states as follows: ‘‘All nationally
recognized entities or subspecialty
boards which seek approval by the
Secretary to certify physicians as MROs
for federal workplace drug testing
programs must submit their
qualifications, a sample examination,
and other necessary supporting
examination materials (e.g., answers,
previous examination statistics or other
background examination information, if
requested). Approval will be based on
an objective review of qualifications that
include a copy of the MRO applicant
application form, documentation that
the continuing education courses are
accredited by a professional
organization, and the delivery method
and content of the examination. Each
approved MRO certification entity must
resubmit their qualifications for
approval every two years. The Secretary
shall publish at least every two years a
notice in the Federal Register listing
those entities and subspecialty boards
that have been approved. This notice is
also available on the internet at https://
www.samhsa.gov/workplace/drugtesting.’’
HHS has completed its review of
entities that certify MROs, in
accordance with requests submitted by
such entities to HHS. The Assistant
Secretary for Mental Health and
Substance Use approves the following
MRO certifying entities that offer MRO
certification through examination:
This notice publishes a list of
the Department of Health and Human
Services (HHS) approved Medical
Review Officers certification entities.
The HHS Mandatory Guidelines for
Federal Workplace Drug Testing
Programs (Mandatory Guidelines),
effective on October 1, 2017, addresses
the role and qualifications of Medical
Review Officers (MROs) and HHS
approval of entities that certify MROs.
DATES: HHS approval is effective August
10, 2022.
FOR FURTHER INFORMATION CONTACT:
Sean J. Belouin, Pharm.D., CAPT,
United States Public Health Service,
Senior Science Policy Advisor,
Substance Abuse and Mental Health
American Association of Medical
Review Officers (AAMRO), P.O. Box
12873, Research Triangle Park, NC
27709, Phone: (919) 489–5407, Fax:
(919) 490–1010, Email: bbrandon@
aamro.com, Website: https://
www.aamro.com/.
Medical Review Officer Certification
Council (MROCC), 3231 S. Halsted St,
#167, Chicago, IL 60608, Phone: (847)
631–0599, Fax: (847) 483–1282,
Email: mrocc@mrocc.org, Website:
https://www.mrocc.org/.
MROPREP, 2108 N St, STE N,
Sacramento, CA 95816, Phone: (669)
299–5348, Email: support@
mroprep.com, Website: https://
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Institutional
Training Program (T32) Review.
Date: October 26, 2022.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John K. Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 959, Bethesda, MD
20892, (301) 451–3398, hayesj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: August 4, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–17142 Filed 8–9–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
HHS Approval of Entities That Certify
Medical Review Officers
AGENCY:
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Services Administration, 5600 Fishers
Lane, Rockville, Maryland 20857;
Telephone: (240) 276–2316; Email:
sean.belouin@samhsa.hhs.gov.
VerDate Sep<11>2014
17:26 Aug 09, 2022
Jkt 256001
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
48683
www.mroprep.com/courses/
mrocourse.
Miriam E. Delphin-Rittmon,
Assistant Secretary for Mental Health and
Substance Use.
[FR Doc. 2022–17156 Filed 8–9–22; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
[OMB Control Number 1615–0113]
Agency Information Collection
Activities; Extension, Without Change,
of a Currently Approved Collection:
MyAppointment
U.S. Citizenship and
Immigration Services, Department of
Homeland Security.
ACTION: 30-Day notice.
AGENCY:
The Department of Homeland
Security (DHS), U.S. Citizenship and
Immigration Services (USCIS) will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995. The purpose of this notice is to
allow an additional 30 days for public
comments.
DATES: Comments are encouraged and
will be accepted until September 9,
2022.
SUMMARY:
Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, must be
submitted via the Federal eRulemaking
Portal website at https://
www.regulations.gov under e-Docket ID
number USCIS–2009–0024. All
submissions received must include the
OMB Control Number 1615–0113 in the
body of the letter, the agency name and
Docket ID USCIS–2009–0024.
FOR FURTHER INFORMATION CONTACT:
USCIS, Office of Policy and Strategy,
Regulatory Coordination Division,
Samantha Deshommes, Chief,
Telephone number (240) 721–3000
(This is not a toll-free number;
comments are not accepted via
telephone message.). Please note contact
information provided here is solely for
questions regarding this notice. It is not
for individual case status inquiries.
Applicants seeking information about
the status of their individual cases can
check Case Status Online, available at
ADDRESSES:
E:\FR\FM\10AUN1.SGM
10AUN1
]]>Agencies
[Federal Register Volume 87, Number 153 (Wednesday, August 10, 2022)]
[Notices]
[Pages 48682-48683]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-17142]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting of the
National Institute of Biomedical Imaging and Bioengineering Special
Emphasis Panel.
The meetings will be closed to the public in accordance with the
provisions set forth in sections
[[Page 48683]]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant
applications and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; Institutional Training
Program (T32) Review.
Date: October 26, 2022.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John K. Hayes, Ph.D., Scientific Review Officer,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707 Democracy Blvd., Suite 959,
Bethesda, MD 20892, (301) 451-3398, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.866,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: August 4, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-17142 Filed 8-9-22; 8:45 am]
BILLING CODE 4140-01-P
